Moderna mRNA Cancer vaccine - Dr Anshuman Kumar
1 Vues de vidéo·28 août 2026
Moderna’s personalized mRNA cancer vaccine, highlighted by Dr. Anshuman Kumar, utilizes genetic data from the tumor to design mRNA tailored to each patient. This technology instructs the immune system to recognize specific neoantigens and attack cancer cells, showing particular promise in the treatment of melanoma.
Généré par IAPeut contenir des erreurs
Résumé vidéo
Généré par IAModerna and Merck have reported positive phase 3 results for a personalized mRNA cancer vaccine targeting high-risk melanoma. Used alongside the drug Keytruda, this tailor-made therapy trains the immune system to attack specific mutations in a patient's tumor, significantly reducing the risk of cancer recurrence or spread. This marks a major milestone in the shift toward personalized oncology.